| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-12-31 FY | 2023-09-30 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $92.78K | – | – | – | – | – |
| Cost of Revenue | $192.94K | – | – | – | – | – |
| Gross Profit | -$100.17K | – | – | – | – | – |
| Operating Expenses | $22.52M | $17.44M | $904.79K | $1.23M | $1.29M | $309.30K |
| R&D | – | – | – | – | – | – |
| SG&A | $3.22M | $17.44M | – | $1.23M | – | – |
| Operating Income | -$22.52M | -$17.44M | -$904.79K | -$1.23M | -$1.29M | -$309.30K |
| Interest Expense | $21.48K | $23.66K | – | $35.48K | – | – |
| Tax Expense | – | – | $0.00 | – | $0.00 | – |
| Net Income | -$16.41M | -$17.82M | -$46.37K | -$1.84M | $53.88K | -$307.95K |
| EPS (basic) | -6.4900 | -0.1200 | – | -0.0100 | 0.0200 | -0.1000 |
| EPS (diluted) | -6.4900 | -0.1200 | – | -0.0100 | – | – |
| Shares (diluted) | $2.53M | $142.68M | – | $137.75M | – | – |